Panzol Pro (Pantoprazole)

Pantoprazole, the active ingredient in Panzol Pro, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Panzol Pro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): improves heartburn and esophageal healing. - Erosive oesophagitis: promotes healing of erosive lesions in the oesophagus. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumours. - Prevention of NSAID‑induced gastric ulcers: reduces the risk of ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: infrequent bowel habit changes.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis. - Acute interstitial nephritis: kidney inflammation. - Severe hypersensitivity reactions: rash, angio‑edema, anaphylaxis. - Osteoporotic fractures: increased risk with long‑term use. - Low magnesium (hypomagnesemia): muscle cramps, arrhythmia. - Liver enzyme elevation: hepatitis‑like picture.

When prescribing Pantoprazole, clinicians should consider several safety aspects: - Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for altered absorption of drugs requiring gastric acidity. - Monitor long‑term users: watch for bone density loss and magnesium levels. - Use cautiously in pregnancy: only if the benefit outweighs the risk. - Avoid in known hypersensitivity to pantoprazole or other PPIs. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture.

Pantoprazole can affect the pharmacokinetics of several medicines. Awareness of the interaction potential helps optimise therapy.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption and loss of efficacy. - HIV protease inhibitors (atazanavir, nelfinavir): markedly decreased plasma levels. - Clopidogrel: diminished antiplatelet effect, increasing cardiovascular risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer monitoring. - Digoxin: modest rise in serum concentration. - Methotrexate (high dose): reduced renal clearance, risk of toxicity.